Company intelligence / Profile preview

Exo-Top Biosciences

United States

Ownership: Private
Development stage: Other

Overview

Exo-Top has established a sustainable, GMP-grade exosome manufacturing platform based on a proprietary Master Cell Bank (MCB) of mesenchymal stem cells; clinical results are not directly available as Exo-Top is a manufacturing supplier

Modalities: Exosome-based therapyNanoparticle
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Exo-Top Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exo-Top Biosciences.

Explore the full profile